` 7747 (Asahi Intecc Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

A
7747
vs
N
Nikkei 225

Over the past 12 months, Asahi Intecc Co Ltd has underperformed Nikkei 225, delivering a return of +16% compared to the Nikkei 225's +29% growth.

Stocks Performance
7747 vs Nikkei 225

Loading
7747
Nikkei 225
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7747 vs Nikkei 225

Loading
7747
Nikkei 225
Difference
www.alphaspread.com

Performance By Year
7747 vs Nikkei 225

Loading
7747
Nikkei 225
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Asahi Intecc Co Ltd vs Peers

Nikkei 225
7747
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Asahi Intecc Co Ltd
Glance View

Market Cap
823.8B JPY
Industry
Health Care

Asahi Intecc Co., Ltd. stands at the intersection of precision engineering and medical innovation, carving a niche in the specialized realm of guide wires and catheters, essential tools in the field of cardiovascular interventions. The company, rooted in Japan, has harnessed its expertise in ultra-fine stainless steel wire ropes—a technology initially honed for industrial purposes—to revolutionize medical devices. Unlike many in the industry, Asahi Intecc integrates its manufacturing vertically, producing components in-house to maintain high standards of quality and performance. This meticulous approach ensures that its products meet the demanding specifications of the medical community. Beyond its cornerstone medical division, the company extends its reach into industrial fields such as robotics and consumer electronics, where its high-precision capabilities are equally prized. The financial scaffolding of Asahi Intecc is built on its ability to consistently deliver innovative solutions that address the needs of an aging global population increasingly susceptible to cardiovascular ailments. Its robust R&D initiatives are pivotal in sustaining its competitive edge, fostering the development of next-generation medical devices that cater to the complex demands of advanced medical procedures. The company capitalizes on a global distribution network, allowing it to tap into burgeoning markets across Asia, Europe, and the Americas. Revenue streams are diversified across product sales, royalties, and collaborative ventures, with significant investments channeled back into research, ensuring that Asahi Intecc maintains a cycle of continuous improvement and adaptation in the fast-evolving med-tech landscape.

Intrinsic Value
Not Available
A
Back to Top